There are no studies available in vertebrates other than mammals, as far as we are 94 aware, regarding the presence of fatty acid sensing mechanisms and their possible relationship 95 with the control of food intake. Fish energy metabolism is rather different than that of 96 sacrificed by decapitation and hypothalamus, hindbrain and Brockmann bodies were taken 164 and stored as previously described (39) . 165 A second set of fish was used to evaluate changes in food intake after IP 166 administration of FA. Fish were randomly assigned to experimental groups in different tanks 167 and fasted for 24 h before injection. Then, 8 fish per group received IP 10 ml·kg -1 injection of 168 saline solution alone (control) or containing oleic acid (60 or 300 µg·kg -1 ) or octanoic acid (60 169 or 300 µg·kg -1 ) previously solubilised in HBP as described above. Food intake was registered 170 for 3 days before treatment (to define basal line data) and then 6 and 24 h after IP treatment. 171
On each time, food was supplied in batches of approx. 10g every 2 min until satiation. After 172 feeding, the food uneaten remaining at the bottom (conical tanks) and feed waste were 173 withdrawn, dried and weighed. The amount of food consumed by all fish in each tank was 174 calculated as previously described as the difference from the feed offered (11,41,42). previously dissolved in DMSO. Food intake was registered as described above. 183
184

Assessment of metabolite levels and enzyme activities 185
Plasma FA, total lipids, triglyceride, and glucose levels were determined 186 enzymatically using commercial kits (Wako Chemicals for FA, Spinreact for total lipids and 187 triglyceride, and Biomérieux for glucose) adapted to a microplate format. 188
Samples used to assess metabolite levels were homogenized immediately by ultrasonic 189 disruption in 7.5 vol of ice-cooled 6% PCA, and neutralized (using 1 mol·l -1 potassium 190 bicarbonate). The homogenate was centrifuged (10,000 g), and the supernatant used to assay 191 tissue metabolites. Tissue FA, total lipids, and triglyceride levels were determined 192 enzymatically using commercial kits as described above for plasma samples. CoA levels were determined by ELISA (Cusabio Biotech). Samples for enzyme activities 194
were homogenized by ultrasonic disruption with 9 vols ice-cold-buffer consisting of 50 195 
Results
249
250
Changes in food intake are shown in Fig. 1 . The administration of oleic acid or 251 octanoic acid induced dose-dependent decreases in food intake, which were also time-252 dependent (Fig. 1A) . Food intake decreased after C75 administration, and this effect was 253 cunteracted by the presence of TOFA (Fig. 1B) . 254
Changes in parameters assessed in plasma are shown in Fig. 2 . Treatment with oleic 255 acid or octanoic acid increased levels of FA ( Fig. 2A) , triglycerides (Fig. 2B) , and total lipids 256 (Fig. 2C ) without affecting glucose (Fig. 2D) . 257
Metabolite levels and enzyme activities evaluated in hypothalamus are shown in Fig.  258 3. IP treatment with increased doses of FA was therefore effective in inducing an increase not 259 only in circulating FA but also in hypothalamic levels of total lipids. These results validate the 260 experimental design, and are in agreement with preliminary experiments in which we 261 evaluated a wide range of fatty acid doses. Thus, treatment with oleic acid or octanoic acid 262 increased levels of FA (Fig. 3A , higher at the low doses used), total lipids ( Fig 3C, not with  263 the high dose of octanoic acid), and malonyl-CoA (Fig. 3D ) and the activities of ACLY (Fig.  264   3E , not with the low dose of oleic acid) and FAS (Fig. 3F , high dose of oleic and low dose of 265 octanoic) whereas a decrease was noticed for triglyceride levels (Fig. 3B , not with the high 266 dose of octanoic acid). No significant changes were noticed for HOAD activity (Fig. 3G) . 267
Changes in mRNA abundance assessed in hypothalamus are shown in Table 2 whereas treatment with the low dose of oleic acid decreased HOAD activity (Fig. 5F ). No 297 significant changes were noticed for total lipid levels ( Fig. 5C ). 298
Changes in mRNA abundance in Brockmann bodies are shown in table 4. The 299 treatment with oleic acid or octanoic acid significantly down-regulated mRNA levels of 300 CPT1b (dose-response effect for octanoic acid), FAS (dose-response effect for both acids) 301
and LXR (only at high doses) whereas an up-regulation was noticed for PPARα (dose-302 response for oleic, no effect for the low dose of octanoic) and SREBP1c (only high doses). 303
Moreover, the treatment with oleic acid up-regulated mRNA levels of ACLY (low dose) and 304 CD36 whereas the treatment with the high dose of octanoic acid down-regulated SUR-like 305 mRNA levels. No changes were noticed for mRNA levels of CPT1a, CS and Kir6.x-like. deleterious effect on glucose homeostasis was described in rainbow trout fed in a high fat diet 315 (12). However, these effects had been never evaluated before using individual FA. In the 316 present study, we evaluated, for the first time in fish, if a treatment with an individual FA, 317 such as oleic acid (a LCFA) or octanoic acid (a MCFA), was able to alter food intake and 318 glucose homeostasis in rainbow trout. The decrease in food intake noticed under our 319 experimental conditions, clearly indicates that FA are involved in the lipid-induced inhibition 320 of food intake, which allows us to suggest the presence of a central FA sensing system 321 involved in the control of food intake. In contrast, no changes were noticed in glycaemia, 322
suggesting that the negative effects of high circulating FA levels could be developed only in 323 fasted fish during chronic exposures or as the result of the interaction with other nutrients or 324 endocrine systems. 325
326
Fatty acid sensing through changes in fatty acid metabolism: impact on food intake and 327
hypothalamic neuropeptides 328
In mammals circulating LCFA act as signals of nutrient surplus in the hypothalamus 329 (26,29). In the present study, the increase in circulating FA are reflected in hypothalamus by 330 increased levels of FA (higher at low doses) and total lipids, and decreased levels of 331 triglycerides. These changes support an increased entry of FA into rainbow trout 332 hypothalamus that once within the tissue may elicit a response in metabolism consistent with 333 a FA sensing mechanism. Therefore, we evaluated changes in several parameters of FA 334 metabolism, which in mammals are related to the main mechanism involved in FA sensing, 335 especially in the hypothalamus. One of those mechanisms is that in which increased LCFA 336 levels in plasma enhanced malonyl-CoA levels in hypothalamus that inhibit the ability of 337
CPT-1 to import FA-CoA into mitochondria for oxidation. Moreover, in mammalian 338 hypothalamus FAS is known to be pharmacologically inhibited under conditions of enhanced 339 FA levels (25,26), and enhanced malonyl-CoA levels can lead to an inhibition of food intake 340 through effects in the expression of orexigenic and anorexigenic neuropeptides. In fish to date 341 there were no similar studies. In rainbow trout hypothalamus the first important issue was to 342 characterize the presence of those components in the brain regions assessed. We were 343 successful in general, and therefore we then evaluated changes in those parameters when 344 rainbow trout were treated with a LCFA like oleic acid and with a MCFA like octanoic acid. 345
In mammalian hypothalamus the FA sensing mechanism related to FA metabolism is 346 were those related to the decrease observed in mRNA abundance of CPT1c after oleic acid 360 (but not octanoic acid) treatment. This difference can be attributed to the fact that in mammals 361 octanoic acid does not require CPT1 for entry in the mitochondria (57), and therefore a 362 similar mechanism could be present in trout. 363
Given the apparently successful characterization of the main lipid-sensing markers in 364 the hypothalamus of rainbow trout, we assessed if this system could be involved in the 365 changes observed in food intake. Thus, the treatment with C75 (FAS inhibitor) induced a 366 decrease in food intake that was reverted by the presence of TOFA (ACC inhibitor) since fish 367 co-treated with C75 and TOFA did not display changes in food intake compared with 368 controls. This response is similar to that observed in mammals (14,16,23) supporting that 369 several of the known mechanisms of FA metabolism involved in the FA sensing system 370 related to the central control of food intake in mammals may be also present in fish. 371
Thus, changes in FA metabolism are known to inhibit food intake in mammals through 372 reduced expression of NPY/AgRP and increased expression of POMC/CART (25-26). In 373 rainbow trout hypothalamus treatment with oleic acid decreased NPY and increased POMC 374 mRNA abundance. Both changes are in the direction of inhibiting food intake and are 375 therefore in agreement with the reduced food intake observed in the present study when 376 rainbow trout was treated with FA. In contrast to the metabolic changes described above in 377 which oleic acid induced similar responses than those elicited by octanoic acid, no major 378 changes were noticed in the expression of neuropeptides like NPY, POMC or CART after 379 octanoic acid treatment, which is also in contrast with the above findings that both octanoic 380 and oleic acid induced a decrease in food intake. In mammals, it has been hypothesized that 381 changes in CPT1c (the CNS specific isoform of CPT1) would be mediating the expression of 382 peptides in mammalian hypothalamus (6). If no changes occur in CPT1c after octanoic 383 treatment in rainbow trout hypothalamus this could be related to the lack of effect of that fatty 384 acid in neuropeptide expression. In this way, in mammals, the anorexigenic effect of FA 385 could depend on the rate of mitochondrial activity since LCFA produce a higher inhibition 386 than MCFA or SCFA (2). In general, we may suggest that rainbow trout hypothalamus posses 387 a FA sensing system based on FA metabolism which was related to the inhibition of food 388 intake. The system seems to be fully activated by a LCFA like oleic acid but only partially 389 activated by a MCFA like octanoic acid since in this later case no changes were noticed in the 390 mRNA abundance of orexigenic and anorexigenic peptides. A recent paper by lipid levels and mRNA levels of ACLY, CPT1c, NPY), whereas only for mRNA levels of 406 FAS changes in hindbrain were similar to those observed in hypothalamus. We may therefore 407 suggest that, in contrast to the mammalian situation where hindbrain has been suggested to be 408 involved in fatty acid sensing through specific changes in FA metabolism (28), this seems not 409 to be the case in rainbow trout. 410
In mammals the ability to sense FA affects insulin secretion in the endocrine pancreas 411 (27,33). In fish, insulin release in pancreatic endocrine tissue is influenced not only by 412 circulating glucose but also by lipid levels, which is not surprising considering the lipogenic 413 role of insulin in fish (4). Therefore, we hypothesize that a system detecting changes in 414 circulating lipid levels may be present in the main accumulation of endocrine pancreatic 415 tissue in fish, the Brockmann bodies, and therefore we evaluated the response of the same 416 components than those addressed in the hypothalamus. The results obtained in BB were in 417 some cases similar to those observed in hypothalamus, like the decreased mRNA levels of 418 FAS and CPT1c after treatment with oleic acid or octanoic acid, which suggests that FA 419 metabolism may be involved in FA sensing capacity in BB. Further studies assessing insulin 420 levels will confirm if this mechanism is related to hormone secretion. to be taken into account in the present study. In fish, as in mammals (58), PPARα attenuates 437 the expression of LXR (7). Therefore, a decrease in LXR mRNA levels could be expected 438 when PPARα mRNA levels increased, as observed in the present study in hypothalamus of 439 fish treated with FA. Therefore, it seems that raised FA levels, especially oleic acid, are also 440 sensed in trout hypothalamus through changes in the expression of CD36 carrier and related 441 transcription factors. In hindbrain no changes were noticed in the same parameters whereas in 442 BB the pathway seems also to be present since enhanced mRNA levels of CD36, PPARα, and 443
SREBP1c were noticed after treatment with oleic acid or octanoic acid. In a way similar to 444 that observed in hypothalamus LXR mRNA levels decreased in BB of fish treated with FA 445 suggesting again a inhibitory relationship with PPARα as demonstrated in flounder liver (7). 446
In mammalian hypothalamus increased FA levels also result in enhanced 447 mitochondrial production of ROS by electron leakage, finally resulting in an inhibition of the 448 K ATP channel activity (3). In our study, we evaluated changes in the mRNA abundance of the 449 components of the K ATP channel (Kir6.x-like and SUR-like) (42) observing a clear inhibition 450 by treatment with both FA. This is in agreement with the response observed in mammals, 451
suggesting that this channel is sensitive to circulating FA and may participate in fatty acid 452 sensing. In contrast, in hindbrain and in BB the pathway related to mitochondrial activity 453 seems not to be working since no changes comparable to those observed in hypothalamus 454 were observed in the mRNA abundance of the components of the K ATP channel (Kir6.x-like 455 and SUR-like). 456
457
Conclusions and perspectives 458
In the present study, we describe for the first time in fish, altered food intake in 459 response to the administration of single FA. Moreover, we have found that several metabolic 460 and molecular components of the main lipid sensing system described in mammals are 461 sensitive to the high circulating FA levels induced in our experimental design. We may then 462 suggest that the increase in circulating LCFA or MCFA levels in rainbow trout are sensed in 463 the hypothalamus through a complex mechanism in which FA metabolism, binding to CD36 464 and mitochondrial activity are apparently involved. The mechanisms are quite similar to those 465 suggested in mammals except for the apparent capacity of rainbow trout hypothalamus to 466 detect increases not only in LCFA but also in MCFA, which could be related to a higher 467 importance of MCFA in teleosts. Changes in those hypothalamic pathways could be related to 468 the control of food intake since food intake was inhibited when the FA metabolism was 469 perturbed (using FAS or ACC inhibitors) and, only after oleic acid treatment, changes in 470 mRNA levels of specific neuropeptides such as NPY and POMC were also noticed in 471 hypothalamus. This response seems to be exclusive of the hypothalamus, since the other 472 centre controlling food intake (hindbrain) was unaffected by treatments. Since FA treatment 473 was given IP further intracerebroventricular (ICV) experiments are necessary to establish that 474 the effects of FA are related to nutrient sensing and not to peripheral hormonal effects. 475
The results obtained in BB suggest that at least two of the components of a putative 476 fatty acid sensing system (based on fatty acid metabolism and binding to CD36) could be 477 present in BB of rainbow trout responding with changes similar to those observed in 478 hypothalamus. However, since no changes were observed in the mRNA levels of the 479 components of the K + ATP channel the fatty acid detection in BB does not seem to be easily 480 related to insulin secretion as suggested in mammals (7). Furthermore, the possibility that in a 481 way similar to mammals the response of BB to raised fatty acid levels in plasma be a 482 consequence of hypothalamic fatty acid sensing through vagal and sympathetic outflow (3) 483 cannot be ruled out and must be addressed in future studies using ICV treatments with FA. 484
In conclusion, lipids had been considered to date in fish only as an important source of 485 energy with an inhibitory relationship with food intake that had not been evaluated before. 
